Here are five additional things to know about Zimmer Biomet’s third-quarter financial results:
1. Zimmer Biomet saw net earnings of $249.1 million, or $353.2 million on an adjusted basis.
2. During the quarter, the company announced the broad commercial launch of the Z1 Femoral Hip System for total hip arthroplasty.
3. Zimmer Biomet acquired OrthoGrid Systems Inc., a privately held medical technology company focused on artificial intelligence-driven surgical guidance systems for total hip replacement.
4. Zimmer Biomet recorded a 53.1% bottom-line gain on a sales uptick of 4%.
5. The company now expects full-year revenue growth between 3.5% and 4%, versus its previous projected range of 4% to 5%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
